The evidence leans constructive7 supporting, 1 against, 1 worth knowing
Supporting
trading 45% above its 200-day average
sitting at 100% of its 52-week range, with little overhead supply from trapped buyers
up 34% over twelve months
matches profit that turns into cash, which has beaten the market by +2.73 points over 20 sessions across 9,184 past signals
7 of the scans it matches have a positive measured record
7 independent kinds of evidence agree today, which is uncommon
revenue grew 33% year on year in the quarter ending 30 June 2026
Against
1 of the scans it matches has historically underperformed the market
Worth knowing
RSI at 84 is stretched; strong stocks stay stretched for a long time, so this is a note on entry timing, not on direction
What would change this read: a close below 1,340, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working7
Revenue rose 40.0% year on year, from Rs 229 cr to Rs 321 cr.
+40.0%Rs 229 crRs 321 cr
Operating cash flow was Rs 112 cr against Rs 95 cr of profit, which is 118% of it.
Rs 112 crRs 95 cr118%
Net profit rose 11.6% year on year, from Rs 24 cr to Rs 26 cr.
+11.6%Rs 24 crRs 26 cr
Trading 45.5% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+45.5%
Within 0.0% of its 52-week high.
-0.0%
Up 34.3% over the past year.
+34.3%
4 different kinds of evidence point at it tonight, not 4 versions of the same one.
4 families
Needs watching3
Profit grew slower than revenue, +11.6% against +40.0%.
+11.6%+40.0%
Net margin moved from 10.3% to 8.2%.
10.3%8.2%
A warning rule fires on it tonight: stretched far above trend.
Stretched far above trend
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 5 of these 5 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
12 of 47 matched on 10 Sep
VENUSPIPES matches 12 of the 47 scans today, across 7 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
500 sessions since 26 September 2024
22×
median 30×
41×
now 42×
VENUSPIPES trades at 42× trailing earnings, above its median of 30× over this window — 43% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 33% against the same quarter a year earlier
net margin narrowed from 8.4% to 8.2%
revenue rose in 4 of the last 4 quarters
Going against it
profit dropped 4% year on year
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
321
36
26
12.75
8.2%
Q4 FY26
31 Mar · standalone
302
35
25
12.38
8.4%
Q3 FY26
31 Dec · standalone
297
34
26
12.46
8.6%
Q3 FY25
31 Dec · standalone
231
24
18
8.84
7.8%
Q2 FY25
30 Sep · standalone
229
32
24
11.63
10.3%
Q1 FY25
30 Jun · standalone
240
37
28
13.58
11.5%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+16.0%
Versus 200-day average+45.5%
Below 52-week high-0.0%
Above 52-week low+118.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)83.8
Higher closes in last 54 of 5
Six-month return+94.54%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)4.31%
Volume versus 20-day0.9x
Median daily turnoverRs 16.9 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.